Cecile Guegan
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2026-08-16
- Valid until
- still holds
- Published
- 2026-06-18
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-13 · its source page states the value and the date, as read by an AI model
- Confidence
- 0.95
Sources
“the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026”— what the page says, read 2026-11-13
Cite this claim
Plain text
AsOf. "Pfizer cfo: Cecile Guegan", as of 2026-08-16. Claim clm_F484D4AA4EC9, https://asof.is/claim/clm_F484D4AA4EC9, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm.
APA
AsOf. (2026). Pfizer cfo: Cecile Guegan (as of 2026-08-16) [Record clm_F484D4AA4EC9]. Retrieved November 13, 2026, from https://asof.is/claim/clm_F484D4AA4EC9 (source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm)
BibTeX
@misc{asof_clm_F484D4AA4EC9,
author = {AsOf},
title = {Pfizer cfo: Cecile Guegan},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_F484D4AA4EC9}},
note = {Claim clm\_F484D4AA4EC9, as of 2026-08-16; source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm},
urldate = {2026-11-13}
}On the record
/claim/clm_F484D4AA4EC9.md/v1/claims/clm_F484D4AA4EC9submit a correction